Login
Sign Up
Login
Sign Up
Features
Pricing
Reg.News
Contact
Login
Sign Up
Search
Providers
Companies
⨯
LIVE
Event in Progress:
Join Here
×
Search
Providers
Companies
⨯
Features
Pricing
Event Hub
Reg.News
Short Interest
Contact
All the news articles and press releases in one place.
UK Reg. News
German Reg. News
Search
Key Announcements
Results / Trading Updates
Get free RNS email alerts for@Model.CurrentFilterValue
Currently filtered for Faron Pharmaceuticals Oy
Clear Filter
Sector
Automobile Industry
Banks
Basic Materials
Building & Construction
Chemicals
Consumer Discretionary Goods
Consumer Discretionary Services
Consumer Staple Goods
Consumer Staple Services
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Finance
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Trusts, ETFs & Funds
Utilities
Market Cap
Below £20m
£20m - £100m
£100m - £300m
£300m - £1bn
£1bn - £10bn
Over £10bn
Filters »
All
UK100
UK250
UK SmallCap
UK Other
Show:
10
25
50
100
«
1
2
3
4
»
Date / Time
Source
Ticker
Company
Sector
Market Cap
Announcement
02Mar18 13:30
RNS
FARN:LON, AV:LON
Aviva plc, Faron Pharmaceuticals Oy
Various
Various
Holding(s) in Company
02Mar18 13:25
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Holding(s) in Company
01Mar18 12:42
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Holdings in Company
01Mar18 12:41
RNS
FARN:LON, LGEN:LON
Faron Pharmaceuticals Oy, Legal & General Group Plc
Various
Various
Holdings in Company
26Feb18 13:37
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Issue of Equity
21Feb18 15:31
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Results of Placing & Issue of Equity
16Feb18 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Proposed Placing to raise up to £15m
29Jan18 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
FDA grants Fast Track Designation for Traumakine®
24Jan18 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
FDA approval of Faron's Traumakine® IND
19Dec17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
INFORAAA trial receives recommendation from IDMC
11Dec17 07:32
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Recruitment completed in Traumakine INTEREST Trial
06Dec17 18:06
RNS
FARN:LON, LGEN:LON
Faron Pharmaceuticals Oy, Legal & General Group Plc
Various
Various
Holding(s) in Company
01Dec17 14:55
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Holdings in Company
24Nov17 10:23
RNS
FARN:LON, LGEN:LON
Faron Pharmaceuticals Oy, Legal & General Group Plc
Various
Various
Holding(s) in Company
21Nov17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Grant of options
20Nov17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Change of Adviser
16Oct17 09:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Holding(s) in Company
13Oct17 09:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Director/PDMR Shareholding
11Oct17 14:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Issue of Equity & PDMR Shareholding
09Oct17 16:30
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Result of Placing & Subscription & Issue of Equity
05Oct17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Proposed Placing and Subscription
02Oct17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Traumakine Receives PIM Designation from MHRA
11Sep17 15:19
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Directors Dealings
06Sep17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Interim Results
04Sep17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
FDA advises Faron to proceed directly to BLA
04Aug17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Update on INTEREST Phase III Study from IDMC
28Jul17 09:34
RNS
FARN:LON, AV:LON
Aviva plc, Faron Pharmaceuticals Oy
Various
Various
Holding(s) in Company
10Jul17 16:51
RNS
FARN:LON, AV:LON
Aviva plc, Faron Pharmaceuticals Oy
Various
Various
Holding(s) in Company
10Jul17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Notice of Results
16Jun17 14:43
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Director/PDMR Shareholding
01Jun17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Exercise of Warrants and Options
30May17 14:06
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Holdings in Company
22May17 11:31
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Director/PDMR Shareholding
22May17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Director/PDMR Shareholding
18May17 09:20
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Director/PDMR Shareholding
16May17 12:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Result of AGM
08May17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Update on INTEREST Phase III Study from IDMC
27Apr17 17:57
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Exercise of Warrants
26Apr17 12:32
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Director's dealings
21Apr17 17:56
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Director/PDMR Shareholding
19Apr17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Proposed Board Changes
19Apr17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Notice of Annual General Meeting
18Apr17 16:17
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Purchase of Shares
18Apr17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Collaboration with Birmingham University
13Apr17 13:43
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Purchase of Shares
04Apr17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Director/PDMR Shareholding
29Mar17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Final Results 2016
27Mar17 09:23
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Holding(s) in Company
07Mar17 10:54
RNS
FARN:LON, LGEN:LON
Faron Pharmaceuticals Oy, Legal & General Group Plc
Various
Various
Holding(s) in Company
07Mar17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Notice of Full Year Results
03Mar17 11:02
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Holding(s) in Company
01Mar17 11:35
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Result of Placing & Subscription & Issue of Equity
28Feb17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Proposed Placing and Subscription
20Feb17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
First Patient Recruited in Phase II RAAA Study
09Feb17 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron update for 2017
09Dec16 13:05
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Notification of Major Interest in Shares
09Dec16 13:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Notification of Major Interest in Shares
05Dec16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
PDMR Shareholding
21Nov16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Grant of options
31Oct16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
New Application Accepted by Finnish Patent Office
24Oct16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
First patient recruited in Japanese Ph III trial
07Oct16 13:41
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Notification of Major Interest in Shares
06Oct16 10:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Notification of Major Interest in Shares
05Oct16 17:10
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Notification of Major Interest in Shares
26Sep16 15:59
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Director Dealing
21Sep16 11:27
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Raises £8.0 M through a Placing and Subscription
20Sep16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Proposed Placing & Subscription to raise £8M
05Sep16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Interim Results for six months ended 30 June 2016
10Aug16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron Pharmaceuticals Notice of Interim Results
14Jun16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron Provides Update at R&D Day
13Jun16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron Licenses Traumakine Rights to Pharmbio Korea
26May16 10:53
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron Result of Annual General Meeting
26May16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron Expands R&D Strategy for Clevegen
13May16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron Pharmaceuticals Ltd to host an R&D Day
04May16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Notice of AGM
03May16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron Appoints New Medical Director
22Apr16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron Appoints Panmure Gordon as Joint Broker
19Apr16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron Files Two New Patents to Protect Clevegen
10Mar16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Annual Results for the year ended 31 December 2015
01Mar16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron files patent application for Traumakine
10Feb16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Notice of Preliminary Results
07Jan16 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Top-line results from Japanese study of Traumakine
29Dec15 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
First Patient recruited in Phase III ARDS Study
21Dec15 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Faron Awarded ?1.5 million Tekes Funding
30Nov15 07:00
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Key Publication in Journal of Immunology
17Nov15 07:30
RNS
FARN:LON
Faron Pharmaceuticals Oy
Health
£94.6m
Admission to AIM and first day of dealings
«
1
2
3
4
»
Date / Time
Source
Company
% Chg
02Mar18 13:30
RNS
Aviva plc, Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
02Mar18 13:25
RNS
Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
01Mar18 12:42
RNS
Faron Pharmaceuticals Oy
0.00%
Holdings in Company
01Mar18 12:41
RNS
Faron Pharmaceuticals Oy, Legal & General Group Plc
0.00%
Holdings in Company
26Feb18 13:37
RNS
Faron Pharmaceuticals Oy
0.00%
Issue of Equity
21Feb18 15:31
RNS
Faron Pharmaceuticals Oy
0.00%
Results of Placing & Issue of Equity
16Feb18 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Proposed Placing to raise up to £15m
29Jan18 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
FDA grants Fast Track Designation for Traumakine®
24Jan18 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
FDA approval of Faron's Traumakine® IND
19Dec17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
INFORAAA trial receives recommendation from IDMC
11Dec17 07:32
RNS
Faron Pharmaceuticals Oy
0.00%
Recruitment completed in Traumakine INTEREST Trial
06Dec17 18:06
RNS
Faron Pharmaceuticals Oy, Legal & General Group Plc
0.00%
Holding(s) in Company
01Dec17 14:55
RNS
Faron Pharmaceuticals Oy
0.00%
Holdings in Company
24Nov17 10:23
RNS
Faron Pharmaceuticals Oy, Legal & General Group Plc
0.00%
Holding(s) in Company
21Nov17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Grant of options
20Nov17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Change of Adviser
16Oct17 09:00
RNS
Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
13Oct17 09:00
RNS
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
11Oct17 14:00
RNS
Faron Pharmaceuticals Oy
0.00%
Issue of Equity & PDMR Shareholding
09Oct17 16:30
RNS
Faron Pharmaceuticals Oy
0.00%
Result of Placing & Subscription & Issue of Equity
05Oct17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Proposed Placing and Subscription
02Oct17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Traumakine Receives PIM Designation from MHRA
11Sep17 15:19
RNS
Faron Pharmaceuticals Oy
0.00%
Directors Dealings
06Sep17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Interim Results
04Sep17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
FDA advises Faron to proceed directly to BLA
04Aug17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Update on INTEREST Phase III Study from IDMC
28Jul17 09:34
RNS
Aviva plc, Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
10Jul17 16:51
RNS
Aviva plc, Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
10Jul17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Notice of Results
16Jun17 14:43
RNS
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
01Jun17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Exercise of Warrants and Options
30May17 14:06
RNS
Faron Pharmaceuticals Oy
0.00%
Holdings in Company
22May17 11:31
RNS
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
22May17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
18May17 09:20
RNS
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
16May17 12:00
RNS
Faron Pharmaceuticals Oy
0.00%
Result of AGM
08May17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Update on INTEREST Phase III Study from IDMC
27Apr17 17:57
RNS
Faron Pharmaceuticals Oy
0.00%
Exercise of Warrants
26Apr17 12:32
RNS
Faron Pharmaceuticals Oy
0.00%
Director's dealings
21Apr17 17:56
RNS
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
19Apr17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Proposed Board Changes
19Apr17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Notice of Annual General Meeting
18Apr17 16:17
RNS
Faron Pharmaceuticals Oy
0.00%
Purchase of Shares
18Apr17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Collaboration with Birmingham University
13Apr17 13:43
RNS
Faron Pharmaceuticals Oy
0.00%
Purchase of Shares
04Apr17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
29Mar17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Final Results 2016
27Mar17 09:23
RNS
Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
07Mar17 10:54
RNS
Faron Pharmaceuticals Oy, Legal & General Group Plc
0.00%
Holding(s) in Company
07Mar17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Notice of Full Year Results
03Mar17 11:02
RNS
Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
01Mar17 11:35
RNS
Faron Pharmaceuticals Oy
0.00%
Result of Placing & Subscription & Issue of Equity
28Feb17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Proposed Placing and Subscription
20Feb17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
First Patient Recruited in Phase II RAAA Study
09Feb17 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron update for 2017
09Dec16 13:05
RNS
Faron Pharmaceuticals Oy
0.00%
Notification of Major Interest in Shares
09Dec16 13:00
RNS
Faron Pharmaceuticals Oy
0.00%
Notification of Major Interest in Shares
05Dec16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
PDMR Shareholding
21Nov16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Grant of options
31Oct16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
New Application Accepted by Finnish Patent Office
24Oct16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
First patient recruited in Japanese Ph III trial
07Oct16 13:41
RNS
Faron Pharmaceuticals Oy
0.00%
Notification of Major Interest in Shares
06Oct16 10:00
RNS
Faron Pharmaceuticals Oy
0.00%
Notification of Major Interest in Shares
05Oct16 17:10
RNS
Faron Pharmaceuticals Oy
0.00%
Notification of Major Interest in Shares
26Sep16 15:59
RNS
Faron Pharmaceuticals Oy
0.00%
Director Dealing
21Sep16 11:27
RNS
Faron Pharmaceuticals Oy
0.00%
Raises £8.0 M through a Placing and Subscription
20Sep16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Proposed Placing & Subscription to raise £8M
05Sep16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Interim Results for six months ended 30 June 2016
10Aug16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron Pharmaceuticals Notice of Interim Results
14Jun16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron Provides Update at R&D Day
13Jun16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron Licenses Traumakine Rights to Pharmbio Korea
26May16 10:53
RNS
Faron Pharmaceuticals Oy
0.00%
Faron Result of Annual General Meeting
26May16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron Expands R&D Strategy for Clevegen
13May16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron Pharmaceuticals Ltd to host an R&D Day
04May16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Notice of AGM
03May16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron Appoints New Medical Director
22Apr16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron Appoints Panmure Gordon as Joint Broker
19Apr16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron Files Two New Patents to Protect Clevegen
10Mar16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Annual Results for the year ended 31 December 2015
01Mar16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron files patent application for Traumakine
10Feb16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Notice of Preliminary Results
07Jan16 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Top-line results from Japanese study of Traumakine
29Dec15 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
First Patient recruited in Phase III ARDS Study
21Dec15 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Faron Awarded ?1.5 million Tekes Funding
30Nov15 07:00
RNS
Faron Pharmaceuticals Oy
0.00%
Key Publication in Journal of Immunology
17Nov15 07:30
RNS
Faron Pharmaceuticals Oy
0.00%
Admission to AIM and first day of dealings
«
1
2
3
4
»
Date / Time
Company
% Chg
02Mar18 13:30
AV. LSE,FARN LSE
0.00%
Holding(s) in Company
02Mar18 13:25
Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
01Mar18 12:42
Faron Pharmaceuticals Oy
0.00%
Holdings in Company
01Mar18 12:41
FARN LSE,LGEN LSE
0.00%
Holdings in Company
26Feb18 13:37
Faron Pharmaceuticals Oy
0.00%
Issue of Equity
21Feb18 15:31
Faron Pharmaceuticals Oy
0.00%
Results of Placing & Issue of Equity
16Feb18 07:00
Faron Pharmaceuticals Oy
0.00%
Proposed Placing to raise up to £15m
29Jan18 07:00
Faron Pharmaceuticals Oy
0.00%
FDA grants Fast Track Designation for Traumakine®
24Jan18 07:00
Faron Pharmaceuticals Oy
0.00%
FDA approval of Faron's Traumakine® IND
19Dec17 07:00
Faron Pharmaceuticals Oy
0.00%
INFORAAA trial receives recommendation from IDMC
11Dec17 07:32
Faron Pharmaceuticals Oy
0.00%
Recruitment completed in Traumakine INTEREST Trial
06Dec17 18:06
FARN LSE,LGEN LSE
0.00%
Holding(s) in Company
01Dec17 14:55
Faron Pharmaceuticals Oy
0.00%
Holdings in Company
24Nov17 10:23
FARN LSE,LGEN LSE
0.00%
Holding(s) in Company
21Nov17 07:00
Faron Pharmaceuticals Oy
0.00%
Grant of options
20Nov17 07:00
Faron Pharmaceuticals Oy
0.00%
Change of Adviser
16Oct17 09:00
Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
13Oct17 09:00
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
11Oct17 14:00
Faron Pharmaceuticals Oy
0.00%
Issue of Equity & PDMR Shareholding
09Oct17 16:30
Faron Pharmaceuticals Oy
0.00%
Result of Placing & Subscription & Issue of Equity
05Oct17 07:00
Faron Pharmaceuticals Oy
0.00%
Proposed Placing and Subscription
02Oct17 07:00
Faron Pharmaceuticals Oy
0.00%
Traumakine Receives PIM Designation from MHRA
11Sep17 15:19
Faron Pharmaceuticals Oy
0.00%
Directors Dealings
06Sep17 07:00
Faron Pharmaceuticals Oy
0.00%
Interim Results
04Sep17 07:00
Faron Pharmaceuticals Oy
0.00%
FDA advises Faron to proceed directly to BLA
04Aug17 07:00
Faron Pharmaceuticals Oy
0.00%
Update on INTEREST Phase III Study from IDMC
28Jul17 09:34
AV. LSE,FARN LSE
0.00%
Holding(s) in Company
10Jul17 16:51
AV. LSE,FARN LSE
0.00%
Holding(s) in Company
10Jul17 07:00
Faron Pharmaceuticals Oy
0.00%
Notice of Results
16Jun17 14:43
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
01Jun17 07:00
Faron Pharmaceuticals Oy
0.00%
Exercise of Warrants and Options
30May17 14:06
Faron Pharmaceuticals Oy
0.00%
Holdings in Company
22May17 11:31
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
22May17 07:00
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
18May17 09:20
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
16May17 12:00
Faron Pharmaceuticals Oy
0.00%
Result of AGM
08May17 07:00
Faron Pharmaceuticals Oy
0.00%
Update on INTEREST Phase III Study from IDMC
27Apr17 17:57
Faron Pharmaceuticals Oy
0.00%
Exercise of Warrants
26Apr17 12:32
Faron Pharmaceuticals Oy
0.00%
Director's dealings
21Apr17 17:56
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
19Apr17 07:00
Faron Pharmaceuticals Oy
0.00%
Proposed Board Changes
19Apr17 07:00
Faron Pharmaceuticals Oy
0.00%
Notice of Annual General Meeting
18Apr17 16:17
Faron Pharmaceuticals Oy
0.00%
Purchase of Shares
18Apr17 07:00
Faron Pharmaceuticals Oy
0.00%
Collaboration with Birmingham University
13Apr17 13:43
Faron Pharmaceuticals Oy
0.00%
Purchase of Shares
04Apr17 07:00
Faron Pharmaceuticals Oy
0.00%
Director/PDMR Shareholding
29Mar17 07:00
Faron Pharmaceuticals Oy
0.00%
Final Results 2016
27Mar17 09:23
Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
07Mar17 10:54
FARN LSE,LGEN LSE
0.00%
Holding(s) in Company
07Mar17 07:00
Faron Pharmaceuticals Oy
0.00%
Notice of Full Year Results
03Mar17 11:02
Faron Pharmaceuticals Oy
0.00%
Holding(s) in Company
01Mar17 11:35
Faron Pharmaceuticals Oy
0.00%
Result of Placing & Subscription & Issue of Equity
28Feb17 07:00
Faron Pharmaceuticals Oy
0.00%
Proposed Placing and Subscription
20Feb17 07:00
Faron Pharmaceuticals Oy
0.00%
First Patient Recruited in Phase II RAAA Study
09Feb17 07:00
Faron Pharmaceuticals Oy
0.00%
Faron update for 2017
09Dec16 13:05
Faron Pharmaceuticals Oy
0.00%
Notification of Major Interest in Shares
09Dec16 13:00
Faron Pharmaceuticals Oy
0.00%
Notification of Major Interest in Shares
05Dec16 07:00
Faron Pharmaceuticals Oy
0.00%
PDMR Shareholding
21Nov16 07:00
Faron Pharmaceuticals Oy
0.00%
Grant of options
31Oct16 07:00
Faron Pharmaceuticals Oy
0.00%
New Application Accepted by Finnish Patent Office
24Oct16 07:00
Faron Pharmaceuticals Oy
0.00%
First patient recruited in Japanese Ph III trial
07Oct16 13:41
Faron Pharmaceuticals Oy
0.00%
Notification of Major Interest in Shares
06Oct16 10:00
Faron Pharmaceuticals Oy
0.00%
Notification of Major Interest in Shares
05Oct16 17:10
Faron Pharmaceuticals Oy
0.00%
Notification of Major Interest in Shares
26Sep16 15:59
Faron Pharmaceuticals Oy
0.00%
Director Dealing
21Sep16 11:27
Faron Pharmaceuticals Oy
0.00%
Raises £8.0 M through a Placing and Subscription
20Sep16 07:00
Faron Pharmaceuticals Oy
0.00%
Proposed Placing & Subscription to raise £8M
05Sep16 07:00
Faron Pharmaceuticals Oy
0.00%
Interim Results for six months ended 30 June 2016
10Aug16 07:00
Faron Pharmaceuticals Oy
0.00%
Faron Pharmaceuticals Notice of Interim Results
14Jun16 07:00
Faron Pharmaceuticals Oy
0.00%
Faron Provides Update at R&D Day
13Jun16 07:00
Faron Pharmaceuticals Oy
0.00%
Faron Licenses Traumakine Rights to Pharmbio Korea
26May16 10:53
Faron Pharmaceuticals Oy
0.00%
Faron Result of Annual General Meeting
26May16 07:00
Faron Pharmaceuticals Oy
0.00%
Faron Expands R&D Strategy for Clevegen
13May16 07:00
Faron Pharmaceuticals Oy
0.00%
Faron Pharmaceuticals Ltd to host an R&D Day
04May16 07:00
Faron Pharmaceuticals Oy
0.00%
Notice of AGM
03May16 07:00
Faron Pharmaceuticals Oy
0.00%
Faron Appoints New Medical Director
22Apr16 07:00
Faron Pharmaceuticals Oy
0.00%
Faron Appoints Panmure Gordon as Joint Broker
19Apr16 07:00
Faron Pharmaceuticals Oy
0.00%
Faron Files Two New Patents to Protect Clevegen
10Mar16 07:00
Faron Pharmaceuticals Oy
0.00%
Annual Results for the year ended 31 December 2015
01Mar16 07:00
Faron Pharmaceuticals Oy
0.00%
Faron files patent application for Traumakine
10Feb16 07:00
Faron Pharmaceuticals Oy
0.00%
Notice of Preliminary Results
07Jan16 07:00
Faron Pharmaceuticals Oy
0.00%
Top-line results from Japanese study of Traumakine
29Dec15 07:00
Faron Pharmaceuticals Oy
0.00%
First Patient recruited in Phase III ARDS Study
21Dec15 07:00
Faron Pharmaceuticals Oy
0.00%
Faron Awarded ?1.5 million Tekes Funding
30Nov15 07:00
Faron Pharmaceuticals Oy
0.00%
Key Publication in Journal of Immunology
17Nov15 07:30
Faron Pharmaceuticals Oy
0.00%
Admission to AIM and first day of dealings
«
1
2
3
4
»
Strapline
Strapline
Question 1
Answer 1
Question 2
Answer 2
Question 3
Answer 3
Question 4
Answer 4
Question 5
Answer 5
Question 6
Answer 6
Question 7
Answer 7
Question 8
Answer 8
Top
Home
Features
Pricing
Event Hub
Reg.News
Short Interest Tracker
Explore Content
Regions
UK
Rest of EMEA
N America
APAC
LatAm
Exchanges
Aquis Apex
Australian Securities Exchange
Canadian Securities Exchange
Euronext Paris
London Stock Exchange (domestic)
SIX Swiss Exchange
Sectors
Automobile Industry
Banks
Building & Construction
Chemicals
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Utilities
Small / Large Cap
UK100
UK250
UK Smallcap
UK Other Main Markets
Other
Private/EIS
EIS Single Company
EIS/SEIS Funds
IHT Products
SEIS Single Company
VCT Funds
Providers
Free/Commissioned
ACF Equity Research
Actio Advisors
Align Research
Atrium Research
BlytheRay
BNP Paribas Exane - Sponsored Research
Brand Communications
BRR Media
Calvine Partners
Capital Access Group
Capital Markets Brokers
Cavendish
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Degroof Petercam
DirectorsTalk
Doceo
Edison
Equity Development
eResearch
Fidante Partners
Five Minute Pitch TV
focusIR
Fundamental Research Corp
Galliano’s Latin Notes
goetzpartners securities Limited
H2 Radnor
Hardman & Co
Holland Advisors
Hypothesis Research
Inbound Capital
Independent Investment Research
InterAxS Global
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Magnitogorsk Iron and steel works
Mello Events
Mining Network
NuWays
Paul Scott
Peel Hunt
piworld.co.uk
Proactive
Progressive Equity Research
Quantum Research Group
QuotedData
RaaS - Research as a Service
Research Tree
Resolve Research
SEAL Advisors Ltd
ShareSoc
Shore Capital
Small Cap Consumer Research LLC
StockBox
Tennyson Securities
The AIC
The Life Sciences Division
Trinity Delta
Turner Pope Investments
UK Investor Group
Vox Markets
VSA Capital
WHIreland
Winterflood Securities
Yellowstone Advisory
Zeus Capital
High Net Worth Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
AlphaValue
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
Baptista Research
BNP Paribas Exane - Sponsored Research
Canaccord Genuity
Cavendish
Couloir Capital
Dowgate Capital
First Berlin
First Sentinel
GSBR Research
Hannam & Partners
Hybridan
Kemeny Capital
Liberum
Longspur Clean Energy
Louis Capital
Magnitogorsk Iron and steel works
Medley Global Advisors
Northland Capital Partners
QuotedData Professional
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
SP Angel
Stanford Capital Partners
Stifel FirstEnergy
Stockdale Securities
Tamesis Partners
Tennyson Securities
The Life Sciences Division
Turner Pope Investments
VSA Capital
WHIreland
Whitman Howard
Yellowstone Advisory
Zeus Capital
Institutional Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
BNP Paribas Exane
BRR Media
Calvine Partners
Canaccord Genuity
Capital Access Group
Cavendish
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Degroof Petercam
DirectorsTalk
Doceo
Dowgate Capital
Edison
Equity Development
eResearch
Fidante Partners
First Berlin
First Sentinel
Five Minute Pitch TV
Fundamental Research Corp
Galliano’s Latin Notes
Goodbody
H2 Radnor
Hannam & Partners
Hardman & Co
Holland Advisors
Hybridan
Inbound Capital
Independent Investment Research
InterAxS Global
Investec Bank
Kemeny Capital
Kepler | Absolute Hedge
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Longspur Clean Energy
Magnitogorsk Iron and steel works
Mello Events
Mining Network
Northland Capital Partners
Numis
NuWays
Panmure Gordon
Peel Hunt
piworld.co.uk
Proactive
Quantum Research Group
QuotedData
RaaS - Research as a Service
Research Tree
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
Small Cap Consumer Research LLC
SP Angel
Stanford Capital Partners
Stifel
StockBox
Tamesis Partners
Tennyson Securities
The AIC
The Life Sciences Division
Trinity Delta
UK Investor Group
Velocity Trade
Vox Markets
VSA Capital
WHIreland
Winterflood Securities
Yellowstone Advisory
Zeus Capital
Contact
Sign Up
Sign In
Share: